Author:
Perkins Rebecca B.,Smith Debi L.,Jeronimo Jose,Campos Nicole G.,Gage Julia C.,Hansen Natasha,Rodriguez Ana Cecilia,Cheung Li C.,Egemen Didem,Befano Brian,Novetsky Akiva P,Martins Sandro,Kalpathy-Cramer Jayashree,Inturrisi Federica,Ahmed Syed Rakin,Marcus Jenna,Wentzensen Nicolas,de Sanjose Silvia,Schiffman Mark
Funder
National Cancer Institute
National Institutes of Health
Subject
Cancer Research,Oncology,Epidemiology
Reference45 articles.
1. World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Published online 2021.
2. Human papillomavirus and cervical cancer;Schiffman;Lancet,2007
3. WHO. One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer. Published online April 11, 2022. Accessed October 10, 2022. 〈https://www.who.int/news/item/11–04-2022-one-dose-human-papillomavirus-(hpv)-vaccine-offers-solid-protection-against-cervical-cancer〉.
4. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis;Arbyn;Lancet Oncol.,2014
5. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors;Massad;Obstet. Gynecol.,2013